The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women. - Wikidata - wikimedia - TriplyDB

The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.

The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.

http://www.wikidata.org/entity/Q37474722

about

Equol: pharmacokinetics and biological actions Botanicals and Their Bioactive Phytochemicals for Women's Health Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation.Protection of trabecular bone in ovariectomized rats by turmeric (Curcuma longa L.) is dependent on extract composition The role of soy in vegetarian diets Androidal fat dominates in predicting cardiometabolic risk in postmenopausal women.Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.Pantoea agglomerans lipopolysaccharide maintains bone density in premenopausal women: a randomized, double-blind, placebo-controlled trial The soy isoflavones for reducing bone loss study: 3-yr effects on pQCT bone mineral density and strength measures in postmenopausal women Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women Dietary isoflavones and bone mineral density during midlife and the menopausal transition: cross-sectional and longitudinal results from the Study of Women's Health Across the Nation Phytoestrogen Study.Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms Bone health nutrition issues in aging The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study.The combined effects of soya isoflavones and resistant starch on equol production and trabecular bone loss in ovariectomised mice.Soy foods: are they useful for optimal bone health?Effects of phytoestrogens on bone mineral density during the menopause transition: a systematic review of randomized, controlled trials.Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype.Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling.Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study.Isoflavone metabolism and bone-sparing effects of daidzein-metabolites.Effects of dietary isoflavones from Puerariae radix on lipid and bone metabolism in ovariectomized rats Flavonoid intake and bone health.Does equol production determine soy endocrine effects?Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D.Phytoestrogens and bone health at different reproductive stages.Health impact of childhood and adolescent soy consumption.Metabolism and health effects of phyto-estrogens.An updated review of dietary isoflavones: Nutrition, processing, bioavailability and impacts on human health.Does soy protein affect circulating levels of unbound IGF-1?Evaluation of the potential antidepressant effects of soybean isoflavones.Calcium-41: a technology for monitoring changes in bone mineral.Malonylglucoside conjugates of isoflavones are much less bioavailable compared with unconjugated β-glucosidic forms in rats.The steady-state serum concentration of genistein aglycone is affected by formulation: a bioequivalence study of bone products Nutrikinetic study of genistein metabolites in ovariectomized mice.Effect of soy isolate protein and resistance exercises on muscle performance and bone health of osteopenic/osteoporotic post-menopausal women.Effects of daidzein and kiwifruit on bone mineral density and equol production in ovariectomised rats.Association between dietary phyto-oestrogens and bone density in men and postmenopausal women.Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison.

P2860

Q24594626-F96DE455-BC2E-475B-89E5-8B4AD9FDAE34 Q28065998-7AF317D0-3A12-40A1-B86B-C8465D4EAABC Q28071946-80804764-0420-4429-9D82-A610E0D4E7F4 Q30985369-4EE34092-1633-48EC-B182-46A9B2F53E95 Q34156447-99D4D87D-76AB-4914-B4B9-BB8367B90A57 Q34247970-03CEB098-DFE1-4CDF-ABBD-8A900134266C Q34442947-2C72EDE8-1958-4651-AED4-2F90151320B2 Q34492996-29BB3743-56AD-4370-A37D-597ECD68C31C Q34635331-FFE38F3C-FC47-4147-8B55-3CC0DD87BB6F Q34666049-621068BF-1386-432B-BB4B-6521857BD271 Q34861920-1E4447FF-E7AF-46DA-AC2C-156DCBB8542C Q35072684-6499BCF2-13C6-4DF2-988C-4C2EC9C8386D Q35164591-B76C0033-123F-4933-801A-27BD49C2F0A0 Q35670854-FBD7CE94-E4D9-437B-B679-467FC2464FD7 Q35904536-8EA5D858-EBEB-4F36-97EF-60A84F5CE42A Q36023010-C2FEA254-B8F9-4401-B484-0B6BF304BE87 Q36059450-D1BC2F5B-FDF2-4FAA-B505-4D7E9D00DCB0 Q36154788-401E9414-46AE-4898-BFAC-3717C77D713D Q36250137-659B7E45-A2D0-437F-B084-EF90722D0559 Q36475945-F3EB258B-5C92-4B8D-89BB-4F1B21DF1ED2 Q36546641-17B1C7B2-7C5A-49D8-BD92-96CB6AF6E7A7 Q36838668-84DDCA7A-BDEF-49D5-A873-07AC3BA62FFB Q37083830-01FAC6CE-C805-4A0A-BC00-E5E0E97AF743 Q37502069-73D526E9-F6B9-4B45-9059-49E71B3767D5 Q37988309-E537D963-C4C1-4F63-AE4F-85205F14046F Q38059828-9F0C3329-0A21-4CA9-B6E2-658AFEA77500 Q38112453-454FC05B-6606-4932-829F-7744202D4CAE Q38609844-201F0C24-F4E6-4DA9-97DE-2A9DA69692BB Q38630555-8D405178-8898-4118-8323-380210A3E04C Q38632579-14CAE1BC-A02B-43EB-A52B-A8E15E2A7498 Q38824693-0598739E-5A4A-43A6-8604-0FD41201AD39 Q38828677-B0980DA0-3EEE-4C16-9642-4EDCAA0C5844 Q39032494-8D1BC086-82A2-4CBA-8344-74458D8B7D77 Q39227464-E4C34955-9696-491D-B241-A1054E3E221F Q41484340-318E9FD9-3A51-44CA-9BB7-8C3C15C07DC7 Q42994335-17FF27B6-46CA-4E10-870C-268BF514F677 Q45290625-12DBE679-4082-42B5-BCA3-DED40E7CCD96 Q45367355-4713F21D-9D5E-42BF-9A6D-0C74F2C6591F Q45718390-AFA345CD-ED36-4FF3-B215-219C65B70FAB Q46601560-5D1D9485-3F13-4C41-91F5-373561F46520

P2860

The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.

http://www.wikidata.org/entity/Q37474722

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

The soy isoflavones for reduci ...... trial in postmenopausal women.

@en

The soy isoflavones for reducing bone loss

@nl

type

label

The soy isoflavones for reduci ...... trial in postmenopausal women.

@en

The soy isoflavones for reducing bone loss

@nl

prefLabel

The soy isoflavones for reduci ...... trial in postmenopausal women.

@en

The soy isoflavones for reducing bone loss

@nl

P1433

Q37474722-F63BD0BA-619F-451F-8A7B-A60B55139E9C

P1476

Q37474722-19F17A46-7399-4533-8E96-7351DF734628

P2093

Q37474722-286ADCB1-DC2F-413C-99E6-153482CF815F

Q37474722-3FBE100B-5A1F-4594-8FED-9C1599D268FC

Q37474722-48AED697-A19A-4943-88B8-88E6D381C107

Q37474722-4B6A20AA-2E42-4DF5-97D2-78E58FC33FA7

Q37474722-4FE916A3-7069-4161-B8DD-724C5B981313

Q37474722-C226C8A0-BFBF-4541-BC5B-46645DDC05C9

Q37474722-D19C888F-709F-455B-A90E-5A68748C1936

Q37474722-D8379400-C75D-4890-8D8A-19D1462050AF

P2860

Q37474722-09EF4A35-EBA7-4146-BFF3-F6FC972138B1

Q37474722-0A485D3F-9442-418D-AEDC-F88BFBDCD9D8

Q37474722-0E283B15-A00E-4A25-A463-1044688E9BF7

Q37474722-108C45A8-2CB6-416B-96D6-3E579A8F950F

Q37474722-12CDF00D-15A8-40F4-9E81-3AAA3769672D

Q37474722-163861BC-D1FD-45DE-8067-483F2E63A3F4

Q37474722-1B5AFAA5-BFDD-42EF-B124-6C230B4CF5D1

Q37474722-25F74D49-E441-4208-A9A7-47C5276436D4

Q37474722-27552910-BCAA-44D9-813B-42304B271740

Q37474722-36EA8D93-C25E-4429-A159-9983B5AA627F

P304

Q37474722-FCDE248B-8DB6-4492-8106-5AAD12A80B78

P31

Q37474722-63125573-8F88-4B5C-8AA5-AE4224E2C6F6

P356

Q37474722-122636C9-55D1-4A85-87ED-E0C0B300944F

P407

Q37474722-0A63C449-10A0-4A78-8A19-E105158C0229

P433

Q37474722-3F999709-1DC9-414A-B6EC-42DAB15BFB5B

P478

Q37474722-9C99C0FC-1A51-430F-A9B8-5AF7BD919D38

P577

Q37474722-C17D66EA-6B18-46BE-A720-D79093AC417E

P5875

Q37474722-C569E541-E623-411F-A1B5-BF47EA85C5FD

P698

Q37474722-06FA0832-C6F0-42EC-B9F9-0237CE820719

P932

Q37474722-82A78109-4BA8-4146-9478-EF482E369D0D

P356

AJCN.2009.28306

P1433

The American Journal of Clinical Nutrition

P1476

The soy isoflavones for reduci ...... trial in postmenopausal women.

@en

P2093

C Theodore Peterson

http://www.w3.org/2001/XMLSchema#string

D Lee Alekel

http://www.w3.org/2001/XMLSchema#string

Jeanne W Stewart

http://www.w3.org/2001/XMLSchema#string

Kathy B Hanson

http://www.w3.org/2001/XMLSchema#string

Kenneth J Koehler

http://www.w3.org/2001/XMLSchema#string

Laura N Hanson

http://www.w3.org/2001/XMLSchema#string

Marta D Van Loan

http://www.w3.org/2001/XMLSchema#string

Mindy S Kurzer

http://www.w3.org/2001/XMLSchema#string

P2860

What is meant by intention to treat analysis? Survey of published randomised controlled trials

One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial

Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.

Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data.

Soy protein consumption and bone mass in early postmenopausal Chinese women.

Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women.

Updated data on proximal femur bone mineral levels of US adults.

Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.

P304

218-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3945/AJCN.2009.28306

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38083318

http://www.w3.org/2001/XMLSchema#string

P698

19906801

http://www.w3.org/2001/XMLSchema#string

P932

2793109

http://www.w3.org/2001/XMLSchema#string